Frontiers in MicrobiologyMicrobiologyPeer-reviewed journal article
The Dictyostelium discoideum - Mycobacterium marinum infection model, a powerful high throughput screening platform for anti-infective compounds
Abstract
Tuberculosis is among the worlds deadliest diseases, causing approximately 2 million deaths annually. The urgent need for new antitubercular drugs has been intensified by the rise of drug-resistant strains. Despite recent advancements, most hits identified through traditional target-based screening exhibit limited efficacy in vivo. Consequently, there is a growing demand for whole-cell-based approaches that directly utilize host-pathogen systems. The Dictyostelium discoideum-Mycobacterium marinum host-pathogen system is a well-established and powerful alternative model system to study mycobacterial infections. In this article, the phenotypic host-pathogen protocol assay is presented here which relies on monitoring M. marinum during its infection of the amoeba D. discoideum. This assay is characterized by its scalability for high-throughput screening, robustness, and ease of manipulation, making it an effective system for compound screening. This system provides not only bacterial load readout via a bioluminescent M. marinum strain, but now also host survival and growth via a fluorescent D. discoideum strain enabling further host characterization by quantifying growth inhibition and potential cytotoxicity. Finally, the system was benchmarked with selected antibiotics and anti-infectives and calculated IC50s and MICs where applicable, demonstrating its capability to differentiate between antibiotics and anti-infective compounds. ImportanceThis methods paper introduces a robust, scalable, and high-throughput phenotypic host-pathogen assay based on the well-established Dictyostelium discoideum-Mycobacterium marinum system. In contrast to conventional target-based drug screening approaches, which often struggle to translate effectively in vivo, this platform directly monitors pathogen-host interactions, providing comprehensive insights into bacterial load, host survival, and potential cytotoxicity. By employing bioluminescent M. marinum and fluorescent D. discoideum strains, we validated the system using established antibiotics and anti-infective compounds, effectively distinguishing their effects through IC50 and MIC calculations.
- organism: mouse
- assay: imaging
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 5
- FWCI
- 3.34
- Field percentile
- top 8%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Discovery of anti-infective compounds against Mycobacterium marinum after biotransformation of simple natural stilbene scaffolds by a fungal secretome
Jahn Nitschke, Robin Huber, … Nabil Hanna·Frontiers in MicrobiologyPeer-reviewed·Sep 17, 2024
- Identification of novel anti-bacterial compounds from a chemically highly diverse pathways-based library using phenotypic screens in amoebae host models
S. Kicka, N. Hanna, … T. Soldati·bioRxiv·Dec 17, 2018
- High-throughput Screening of Compounds against Autoluminescent Nonreplicating Mycobacterium tuberculosis under Diverse Conditions
Xirong Tian, Wan-Li Ma, … Tianyu Zhang·bioRxiv·Mar 10, 2024
- Rapid Screening and Validation of Intracellularly Active Antimycobacterial Compounds with Efficacy in Cellular and Murine Tuberculosis Models
Mahima Madan, Kanika Bisht, … Vivek Rao·bioRxiv·Sep 23, 2025
- Screening of anti-mycobacterial compounds in a naturally infected zebrafish embryo model
J.P. Dalton, B. Uy, … S. Wiles·bioRxiv·Feb 4, 2016
- Time-resolved RNA-seq profiling of the infection of Dictyostelium discoideum by Mycobacterium marinum reveals an integrated host response to damage and stress
N. Hanna, Frédéric Burdet, … Thierry Soldati·bioRxiv·Mar 27, 2019